Cancer Charity-funded

Cancer Research UK

Research funded by Cancer Research UK

Funded awards
4,518
Published funding
£1.1M
Active funded awards
513

Amounts are published for 1 of 4,518 funded awards — most Cancer Research UK grants do not disclose funding.

Search funded awards from Cancer Research UK →

Cancer Research UK funds most in Cancer — 2,936 grants (65%). Its largest recipient is University of Cambridge, with 405 grants.

Funded Awards by Year

View data table
YearFunded awards
2006334
2007429
2008317
2009262
2010227
2011246
2012189
2013180
2014229
2015246
2016201
2017168
2018207
2019263
2020166
2021161
2022235
2023187
2024220
202550

Grants

International Cancer Benchmarking Partnership (ICBP) SurvMark-2Centre international de recherche sur le cancerCRUK£1.1M2017Completed
A biology informed approach to prevent gastric cancer in high-risk individualsUniversity of CambridgeCRUKNot disclosed2025Active
A translational programme for DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly-defined Indications using a National Evaluation platform trial)University of BirminghamCRUKNot disclosed2025Active
ACED Manchester Centre Award QQ2University of ManchesterCRUKNot disclosed2025Active
Advanced Ultrasound Imaging for Early Cancer Detection and DiagnosisKing's College LondonCRUKNot disclosed2025Completed
Advancing MRI Biomarkers of the Tumour Microenvironment for Patient BenefitInstitute of Cancer ResearchCRUKNot disclosed2025Active
Cancer Data Driven Detection (CD3)University of CambridgeCRUKNot disclosed2025Active
Cancer diagnosis in people with disability: a multi-methods international project on diagnostic pathways and cancer outcomesUniversity College LondonCRUKNot disclosed2025Completed
CRUK Edinburgh-UCL Brain Tumour Centre Of Excellence 2024University College LondonCRUKNot disclosed2025Active
CRUK Edinburgh-UCL Brain Tumour Centre Of Excellence 2024University of EdinburghCRUKNot disclosed2025Active
Deciphering the dynamics of melanoma plasticityUniversity of ManchesterCRUKNot disclosed2025Active
Decoding spatiotemporal heterogeneity of neutrophil subsets during ovarian cancerUniversity of OxfordCRUKNot disclosed2025Active
Decoding the Signs: Early Detection of High-risk Oral Pre-Malignant LesionsUniversity College LondonCRUKNot disclosed2025Active
Defining the origins and vulnerabilities of cancer chromosomal instabilityQueen Mary University of LondonCRUKNot disclosed2025Active
Detection and characterisation of p53 aggregates in liquid biopsy with ultrasensitive immunoassaysUniversity of CambridgeCRUKNot disclosed2025Active
Developing a community pharmacy service to facilitate early diagnosis of bowel cancer: A rapid ethnographic study”University College LondonCRUKNot disclosed2025Completed
Developing new cell models for brain tumours which use the Alternative Lengthening of Telomeres pathwayUniversity of OxfordCRUKNot disclosed2025Completed
Developing targeted strategies for precision breast cancer preventionUniversity of ManchesterCRUKNot disclosed2025Active
Diverse public perspectives in cancer screening and early diagnosis: generating evidence to support policy (the PERSPECTIVES project)Queen Mary University of LondonCRUKNot disclosed2025Active
Early detection of relapse in multiple myeloma patients with high risk genetics using quantitative immunoprecipitation-mass spectrometry (QIP-MS) in blood: an enhanced surveillance platform for the Myeloma XV, RADAR trial.University of OxfordCRUKNot disclosed2025Active

Page 1 of 3